Clinical Trial Update: Biomarkers in Patients With Head and Neck Cancer

View source ↗

Summary

The update notes that the ECOG-ACRIN Cancer Research Group study on biomarkers in head and neck cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Head and Neck Cancer | Status: COMPLETED